Study shows AIDS drug Tenofovir protects many drug users; US ambassador comments скачать в хорошем качестве

Study shows AIDS drug Tenofovir protects many drug users; US ambassador comments

(13 Jun 2013) 1. Wide of panellists walking to table at start of press conference 2. Cutaway of crowd 3. Pan of panellists 4. Cutaway of crowd 5. SOUNDBITE: (English) Doctor Michael Martin, Chief of Clinical Research for the Tenofovir Study, US Centre for Disease Control: "There were 17 HIV infections among participants in the tenofovir group, and 33 in those assigned to placebo. This translates to a 49 percent reduction in the risk of HIV infection among participants taking Tenofovir, with a 95 percent confidence interval of 9.6 to 72.2, and a P-value of 0.01, a statistically significant result." 6. Cutaway of cameraman 7. SOUNDBITE: (Thai) Kachit Choopanya, Principal investigator of the trial: "The result shows clear evidence using this drug to prevent HIV infection is safe and effective in reducing infection among injected drug users." 8. Cutaway or crowd 9. SOUNDBITE: (English) Kristie Kenney, US Ambassador to Thailand: "This is going to show us, I think, very very importantly the results of new prevention methods for users of drugs, drugs injectors, and men who have sex with men. This is a study that has been carried on throughout Thailand, it's important research, and again it's a huge step forward in our shared (US-Thailand) collaboration." 10. Wide of crowd 11. Wide of press conference STORYLINE: A new study shows that a daily dose of an AIDS drug could help reduce the risk of HIV infection among injecting drug users, US and Thai health official said in Bangkok on Thursday. The study, by the US Centre for Disease Control and Prevention and the Thai government, was carried out in Thailand from 2005 to 2012. The results were published online on Wednesday by the medical journal The Lancet. The study looked at about 2,413 uninfected men and women at 17 drug treatment clinics in Bangkok. Half the participants received daily Tenofovir and half were given a dummy pill. All got condoms and counselling to discourage the spread of HIV. The results showed that volunteers who took the daily pill were 49 percent less likely to become infected than those given a dummy pill. "There were 17 HIV infections among participants in the Tenofovir group, and 33 in those assigned to placebo. This translates to a 49 percent reduction in the risk of HIV infection among participants taking Tenofovir," said Dr. Michael Martin, Chief of Clinical Research for the study from the US Centre for Disease Control and Prevention. Based on the findings, the US Centre for Disease Control and Prevention (CDC) recommended that doctors consider prescribing Tenofovir to those who inject drugs. The drug blocks HIV from making copies and spreading through the body. In the US, Tenofovir is included in an AIDS drug called Truvada. "The result shows clear evidence using this drug to prevent HIV infection is safe and effective in reducing infection among injected drug users," says Kachit Choopanya, the trial's principal investigator. HIV infections in drug users is a bigger problem worldwide, where they account for about one in 10 new cases each year and the vast majority of infections in some places in Eastern Europe and central Asia. In the US, they represent about one in 13 new cases. People who inject drugs can spread the AIDS virus to others through sharing tainted needles or sex. How many people already take the drug in the US to protect against infection isn't known. The CDC only began recommending it for that purpose in the last two years, while health officials acknowledge it's not clear how many of the nation's one million injecting drug users would have the money or insurance to pay for it. Find out more about AP Archive: http://www.aparchive.com/HowWeWork Twitter:   / ap_archive   Facebook:   / aparchives   ​​ Instagram:   / apnews   You can license this story through AP Archive: http://www.aparchive.com/metadata/you...